CH487134A - Procédé de préparation d'esters de la 21-désoxyprednisolone - Google Patents

Procédé de préparation d'esters de la 21-désoxyprednisolone

Info

Publication number
CH487134A
CH487134A CH192067A CH192067A CH487134A CH 487134 A CH487134 A CH 487134A CH 192067 A CH192067 A CH 192067A CH 192067 A CH192067 A CH 192067A CH 487134 A CH487134 A CH 487134A
Authority
CH
Switzerland
Prior art keywords
deoxyprednisolone
esters
preparing
deoxyprednisolone esters
Prior art date
Application number
CH192067A
Other languages
English (en)
French (fr)
Inventor
Oxley Peter
Rosindale Housley John
Original Assignee
Boots Pure Drug Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Pure Drug Co Ltd filed Critical Boots Pure Drug Co Ltd
Priority to CH590469A priority Critical patent/CH491897A/fr
Publication of CH487134A publication Critical patent/CH487134A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/913—Aspergillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/939—Rhizopus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH192067A 1966-02-09 1967-02-09 Procédé de préparation d'esters de la 21-désoxyprednisolone CH487134A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CH590469A CH491897A (fr) 1966-02-09 1967-02-09 Procédé de préparation de 17-acyloxy-stéroïdes

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB571966 1966-02-09
GB56249/66A GB1158492A (en) 1966-02-09 1966-02-09 Improvements in Acylated Steroids
GB3001868 1966-02-09

Publications (1)

Publication Number Publication Date
CH487134A true CH487134A (fr) 1970-03-15

Family

ID=27254686

Family Applications (1)

Application Number Title Priority Date Filing Date
CH192067A CH487134A (fr) 1966-02-09 1967-02-09 Procédé de préparation d'esters de la 21-désoxyprednisolone

Country Status (8)

Country Link
US (1) US3506694A (OSRAM)
CH (1) CH487134A (OSRAM)
DK (1) DK117896B (OSRAM)
FR (2) FR1513708A (OSRAM)
GB (2) GB1159490A (OSRAM)
NL (1) NL151630B (OSRAM)
NO (1) NO127577B (OSRAM)
SE (1) SE342239B (OSRAM)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856956A (en) * 1967-02-02 1974-12-24 Boots Pure Drug Co Ltd 17-acyloxysteroids and their manufacture
FR2559156B1 (fr) * 1984-02-03 1989-03-24 Roussel Uclaf Procede de preparation de derives de la prednisone et produits intermediaires de ce procede
JP2655190B2 (ja) * 1989-06-21 1997-09-17 エスエス製薬 株式会社 コルチコステロイド含有軟膏剤
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
CA2634715A1 (en) 2000-08-05 2002-02-14 Glaxo Group Limited 6.alpha.,9.alpha.-difluoro-17.alpha.-[(2-furanylcarboxyl)oxy}-11.beta.-hydroxy-16.alpha-methyl-3-oxo-androsta-1,4-diene-17.beta.carbothioic acids-fluoromethyl ester as an anti-inflammatory agent
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
CA2445839A1 (en) * 2001-04-30 2002-11-07 Glaxo Group Limited Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
WO2002100879A1 (en) * 2001-06-12 2002-12-19 Glaxo Group Limited Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
BRPI0413330A (pt) * 2003-08-29 2006-10-10 Ranbaxy Lab Ltd inibidores de fosfodiesterase do tipo iv, composição farmacêutica contendo os mesmos e processo para sua preparação
US20070259874A1 (en) * 2003-11-26 2007-11-08 Palle Venkata P Phosphodiesterase Inhibitors
US20080009535A1 (en) * 2004-08-30 2008-01-10 Sarala Balachandran Inhibitors of phosphodiesterase type-IV
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
EP1934219A1 (en) 2005-09-16 2008-06-25 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
AU2006305619A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
BRPI0617673C1 (pt) * 2005-10-19 2012-05-22 Ranbaxy Lab Ltd composições de inibidores de fosfodiesterase do tipo iv
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
BRPI0717058A2 (pt) * 2006-09-22 2013-10-15 Ranbaxy Lab Ltd Composto, composição farmacêutica, método para tratar, prevenir, inibir ou suprimir uma condição inflamatória ou doença ou doenças do sistema nervoso central e método para a preparação de um composto
US20100029728A1 (en) * 2006-09-22 2010-02-04 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
EP1958947A1 (en) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
CA2680625C (en) * 2007-03-14 2016-02-23 Ranbaxy Laboratories Limited Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors
US20110130403A1 (en) * 2007-03-14 2011-06-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
CN102372762B (zh) * 2010-08-18 2012-11-07 天津金耀集团有限公司 一种孕甾11位β羟基合成的工艺
CN107556357A (zh) * 2017-09-28 2018-01-09 湖南科瑞生物制药股份有限公司 丙酸地泼罗酮的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2923721A (en) * 1955-12-13 1960-02-02 Lab Francais Chimiotherapie Method of preparing 3-keto delta1, 4 steroids
US2902410A (en) * 1957-09-26 1959-09-01 Upjohn Co Process for the 1,2-dehydrogenation of a steroid with septomyxa

Also Published As

Publication number Publication date
DE1618095A1 (de) 1971-03-25
US3506694A (en) 1970-04-14
NL151630B (nl) 1976-12-15
SE342239B (OSRAM) 1972-01-31
DE1618095B2 (de) 1975-09-18
GB1159490A (en) 1969-07-23
GB1158492A (en) 1969-07-16
DK117896B (da) 1970-06-15
FR6137M (OSRAM) 1968-06-24
NL6701919A (OSRAM) 1967-08-10
NO127577B (OSRAM) 1973-07-16
FR1513708A (fr) 1968-02-16

Similar Documents

Publication Publication Date Title
CH487134A (fr) Procédé de préparation d'esters de la 21-désoxyprednisolone
CH475285A (fr) Procédé de préparation d'organotrisiloxanes
FR1474903A (fr) Procédé de préparation d'epsiloncaprolactone
CH485769A (fr) Procédé de préparation d'esters de la diméthylsulfamoyl-3 hydroxyéthyl pipéridinopropyl-10 phénothiazine
FR1509372A (fr) Procédé de préparation d'esters glycoliques
FR1474098A (fr) Procédé de préparation d'epsilon-caprolactone
FR1507525A (fr) Procédé de préparation d'imino-dérivés de 5-nitro-(2)-furfurylidène
FR1522825A (fr) Procédé de préparation d'alpha-amino-alpha-méthyl-propionanilides
FR1547627A (fr) Procédé de préparation d'esters n-carbamoyloxyphényl-carbamiques
CH521309A (fr) Procédé de préparation d'esters d'aminoalcoxyphénols
FR1482092A (fr) Procédé de préparation d'iodofluoroalcanes
FR1518386A (fr) Procédé de préparation d'aza-dioxa-bicyclo-alcanes
FR1532167A (fr) Procédé de préparation de l'hydrotalcite
FR1491412A (fr) Procédé de préparation d'organotrisiloxanes
FR1523793A (fr) Procédé de préparation d'esters vinyliques
FR1547223A (fr) Procédé de préparation d'esters phényliques
FR1480084A (fr) Procédé de préparation d'esters de l'acide acétyl-acétique
FR1530972A (fr) Procédé de préparation d'esters de stéroïde
FR1479100A (fr) Procédé de préparation d'esters omicron, omicron-dialcoyl-acyloxy-l-trichloro-2, 2, 2-éthyl-phosphoniques
FR1523544A (fr) Procédé de préparation d'esters insaturés
FR1535208A (fr) Procédé de préparation d'alcénones
FR1540866A (fr) Procédé de préparation d'iodopentafluoroéthane
FR1536633A (fr) Procédé de préparation d'alcoyl-mercapto-anilides
CH484018A (fr) Procédé de préparation d'halogéno-1 méthyl-3 butène-2
FR1516696A (fr) Procédé de préparation d'esters vinyliques

Legal Events

Date Code Title Description
PFA Name/firm changed

Owner name: THE BOOTS COMPANY PLC

PL Patent ceased